243 related articles for article (PubMed ID: 23664530)
21. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
22. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
[TBL] [Abstract][Full Text] [Related]
23. [Sjögren's syndrome and non-Hodgkin's lymphoma: from pathophysiology to treatment].
Le Guern V; Mouthon L
Presse Med; 2011 Dec; 40(12 Pt 1):1113-9. PubMed ID: 21964038
[TBL] [Abstract][Full Text] [Related]
24. Membraneous glomerulonephritis and non-Hodgkin's lymphoma in a patient with primary Sjögren's syndrome.
Iwanaga N; Kamachi M; Fujikawa K; Aramaki T; Izumi Y; Arima K; Tamai M; Aratake K; Nakamura H; Origuchi T; Ida H; Kawakami A; Taguchi T; Eguchi K
Intern Med; 2007; 46(4):191-4. PubMed ID: 17301515
[TBL] [Abstract][Full Text] [Related]
25. Sjögren's syndrome, glomerulonephritis and malignant lymphoma.
Sugai S
Intern Med; 2007; 46(4):155-6. PubMed ID: 17301508
[No Abstract] [Full Text] [Related]
26. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome.
Ioannidis JP; Vassiliou VA; Moutsopoulos HM
Arthritis Rheum; 2002 Mar; 46(3):741-7. PubMed ID: 11920410
[TBL] [Abstract][Full Text] [Related]
27. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.
Baldini C; Pepe P; Quartuccio L; Priori R; Bartoloni E; Alunno A; Gattamelata A; Maset M; Modesti M; Tavoni A; De Vita S; Gerli R; Valesini G; Bombardieri S
Rheumatology (Oxford); 2014 May; 53(5):839-44. PubMed ID: 24369420
[TBL] [Abstract][Full Text] [Related]
28. [The natural course of primary Sjögren's syndrome (a clinical study)].
Pavlidis NA; Drosos AA; Galanopoulos V; Siamopoulos C; Tsianos EB
Ter Arkh; 1988; 60(4):64-7. PubMed ID: 3394101
[TBL] [Abstract][Full Text] [Related]
29. Mortality in Sjögren's syndrome.
Voulgarelis M; Tzioufas AG; Moutsopoulos HM
Clin Exp Rheumatol; 2008; 26(5 Suppl 51):S66-71. PubMed ID: 19026146
[TBL] [Abstract][Full Text] [Related]
30. Association between primary Sjögren's syndrome and non-Hodgkin's lymphoma.
Opriş D; Iosif CI; Predeţeanu D
Rom J Intern Med; 2004; 42(4):715-23. PubMed ID: 16366143
[TBL] [Abstract][Full Text] [Related]
31. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
[TBL] [Abstract][Full Text] [Related]
32. Sjögren's syndrome-associated interstitial lung disease: A multicenter study.
Reina D; Roig Vilaseca D; Torrente-Segarra V; Cerdà D; Castellví I; Díaz Torné C; Moreno M; Narváez J; Ortiz V; Blavia R; Martín-Baranera M; Corominas H
Reumatol Clin; 2016; 12(4):201-5. PubMed ID: 26573882
[TBL] [Abstract][Full Text] [Related]
33. Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome.
Tobón GJ; Saraux A; Gottenberg JE; Quartuccio L; Fabris M; Seror R; Devauchelle-Pensec V; Morel J; Rist S; Mariette X; De Vita S; Youinou P; Pers JO
Arthritis Rheum; 2013 Dec; 65(12):3218-27. PubMed ID: 23982978
[TBL] [Abstract][Full Text] [Related]
34. Germinal centres in diagnostic labial gland biopsies of patients with primary Sjögren's syndrome are not predictive for parotid MALT lymphoma development.
Haacke EA; van der Vegt B; Vissink A; Spijkervet FKL; Bootsma H; Kroese FGM
Ann Rheum Dis; 2017 Oct; 76(10):1781-1784. PubMed ID: 28710097
[TBL] [Abstract][Full Text] [Related]
35. Risk of non-Hodgkin's lymphoma in primary Sjögren's syndrome: a population-based study.
Johnsen SJ; Brun JG; Gøransson LG; Småstuen MC; Johannesen TB; Haldorsen K; Harboe E; Jonsson R; Meyer PA; Omdal R
Arthritis Care Res (Hoboken); 2013 May; 65(5):816-21. PubMed ID: 23139233
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
[TBL] [Abstract][Full Text] [Related]
37. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
Nocturne G; Seror R; Fogel O; Belkhir R; Boudaoud S; Saraux A; Larroche C; Le Guern V; Gottenberg JE; Mariette X
Arthritis Rheumatol; 2015 Dec; 67(12):3226-33. PubMed ID: 26359802
[TBL] [Abstract][Full Text] [Related]
38. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
[TBL] [Abstract][Full Text] [Related]
39. The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study.
De Vita S; Gandolfo S; Zandonella Callegher S; Zabotti A; Quartuccio L
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):150-156. PubMed ID: 30156548
[TBL] [Abstract][Full Text] [Related]
40. Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use.
Fragkioudaki S; Mavragani CP; Moutsopoulos HM
Medicine (Baltimore); 2016 Jun; 95(25):e3766. PubMed ID: 27336863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
